Yibin Xu

Title: Yibin Xu and Mitochondrial-Targeting Inventions.

Introduction

Yibin Xu is an inventor associated with Ann Arbor, Michigan, and the University of Michigan. His work includes a patent application concerning compounds designed to target mitochondria and their potential therapeutic uses.

Latest Patents

Xu is associated with one patent: “Mitochondrial Targeting Compounds for the Treatment of Associated Diseases.” The invention describes compounds intended to address cancer and other disorders associated with mitochondrial function, including diabetes, autoimmune and inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases. It also covers preparation methods, pharmaceutical compositions, treatment methods, prodrugs, and uses of the compounds. Xu’s reported patent count is 1 patent.

Career Highlights

Xu’s listed affiliation is the University of Michigan. The patent’s focus on mitochondrial targeting reflects an effort to develop potential therapeutic approaches for a range of diseases.

Collaborations

Nouri Neamati and Ding Xue are identified as Xu’s coworkers.

Conclusion

Yibin Xu’s patent work, associated with the University of Michigan, centers on mitochondrial-targeting compounds and their potential applications in treating cancer and other diseases.